Plagiocephaly and Craniosynostosis Treatment – Commercial and Individual Exchange Medical Policy
Defines UnitedHealthcare Commercial and Individual Exchange coverage stance for cranial orthotic devices used for infants with craniosynostosis post-surgery and for nonsynostotic (deformational/positional) plagiocephaly, and references InterQual durable medical equipment criteria and related policies for surgery and repairs/replacements.
Template Update created shared policy version to support application to Oxford plan membership and archived previous policy versions 2025T0031FF and SURGERY 114.9.
Coverage Summary
UnitedHealthcare Commercial and Individual Exchange plans are covered under this policy (Plagiocephaly and Craniosynostosis Treatment, Policy Number 2026T0031GG, effective January 1, 2026). The policy defines coverage for cranial orthotic devices for infants following craniosynostosis surgery and for infants with nonsynostotic (deformational/positional) plagiocephaly, with medical necessity determinations made per the InterQual CP: Durable Medical Equipment, Orthoses, Cranial Remodeling criteria.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.